Organ-limited amyloidosis

amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.

Endpoint definition

Long name Organ-limited amyloidosis
Hospital Discharge registry ICD-10: E854
Cause of Death registry ICD-10: E854
Level in the ICD-hierarchy 4
First defined in version DF2
Latin name Amyloidosis in uno organo

Summary Statistics

Key figures

All Female Male
Number of individuals 36 16 20
Unadjusted prevalence (%) 0.02 0.01 0.02
Mean age at first event (years) 69.11 65.13 72.29
Case fatality at 5-years (%) 55.56 37.50 70.00

Longitudinal metrics

All Female Male
Median nb. of events per indiv. 1.0 1.0 1.0
Recurrence at 6 months (%) 25.00 31.25 20.00

Survival analyses between endpoints


before Organ-limited amyloidosis
after Organ-limited amyloidosis

Loading survival analyses plot…

Drugs most likely to be purchased after Organ-limited amyloidosis